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epitope-specific suppression  
of igg responses by Passively 
administered specific igg:  
evidence of epitope Masking
Joakim J. E. Bergström†, Hui Xu† and Birgitta Heyman*
Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden
Specific IgG, passively administered together with particulate antigen, can completely 
prevent induction of antibody responses to this antigen. The ability of IgG to suppress 
antibody responses to sheep red blood cells (SRBCs) is intact in mice lacking FcγRs, 
complement factor 1q, C3, or complement receptors 1 and 2, suggesting that 
Fc-dependent effector functions are not involved. Two of the most widely discussed 
explanations for the suppressive effect are increased clearance of IgG–antigen 
complexes and/or that IgG “hides” the antigen from recognition by specific B  cells, 
so-called epitope masking. The majority of data on how IgG induces suppression 
was obtained through studies of the effects on IgM-secreting single spleen cells 
during the first week after immunization. Here, we show that IgG also suppresses 
antigen-specific extrafollicular antibody-secreting cells, germinal center B-cells, long-
lived plasma cells, long-term IgG responses, and induction of memory antibody 
responses. IgG anti-SRBC reduced the amount of SRBC in the spleens of wild-type, 
but not of FcγR-deficient mice. However, no correlation between suppression and the 
amount of SRBC in the spleen was observed, suggesting that increased clearance 
does not explain IgG-mediated suppression. Instead, we found compelling evidence 
for epitope masking because IgG anti-NP administered with NP-SRBC suppressed 
the IgG anti-NP, but not the IgG anti-SRBC response. Vice versa, IgG anti-SRBC 
administered with NP-SRBC, suppressed only the IgG anti-SRBC response. In 
conclusion, passively transferred IgG suppressed all measured parameters of an 
antigen-specific antibody/B  cell response and an important mechanism of action is 
likely to be epitope masking.
Keywords: Fcγr, complement, sheep erythrocytes, igg-mediated immune suppression, rhesus prophylaxis, 
rhesus D antigen
Abbreviations: BCR, B  cell receptor; C1q, complement factor 1q; C3, complement factor 3; ELISPOT, enzyme-linked 
immunospot assay; ELISA, enzyme-linked immunosorbent assay; FcγR, Fc gamma receptor; FcRγ, Fc receptor gamma chain; 
FcRn, the neonatal Fc receptor; GC, germinal center; HEL, hen egg lysozyme; HOD, HEL-OVA-duffy tandem protein; ITIM, 
immunoreceptor tyrosine-based inhibitory motif; MZ, marginal zone; NP, 4-hydroxy-3-nitrophenyl acetyl; OVA, ovalbumin; 
PFC, plaque-forming cell assay; RhD, rhesus D antigen; SRBCs, sheep red blood cells; TNP, 2,4,6-trinitrophenyl.
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inTrODUcTiOn
When antibodies are passively administered together with their 
specific antigen, they either down- or upregulate the antibody 
response against this antigen (1–3). IgM, IgG, and IgE enhance 
antibody responses and their effects depend on interactions of the 
immune complexes with Fc- or complement receptors, causing 
more efficient delivery of antigen to splenic B cell follicles and/
or causing enhanced presentation of antigen to CD4+ T  cells. 
Interestingly, IgG has a dual role and the same monoclonal 
IgG anti-2,4,6-trinitrophenyl that enhances carrier responses 
when administered with haptenated proteins, suppresses carrier 
responses when administered with haptenated erythrocytes (4, 
5). Since the 1960s, the suppressive capacity of IgG has been used 
clinically to protect rhesus D antigen (RhD)-negative women 
from becoming immunized against fetal RhD-positive erythro-
cytes entering the maternal circulation through transplacental 
hemorrhage (6). Administration of IgG anti-RhD to these women 
has significantly reduced the frequency of hemolytic disease of 
the fetus and newborn (7). The mechanism behind the dramatic 
ability of IgG to suppress antibody responses has been elusive. 
It is of substantial theoretical interest to understand how small 
amounts of IgG can completely prevent antibody responses to the 
antigen they recognize. Understanding these mechanisms may 
also aid in finding effective monoclonal IgG anti-RhD antibodies 
to use in RhD-prophylaxis.
In the majority of previous studies of IgG-mediated sup-
pression, the number of B cells producing sheep red blood cell 
(SRBC)-specific IgM during the first week after immunization 
was analyzed in mice immunized with native SRBC  ±  IgG 
anti-SRBC or haptenated SRBC ±  IgG anti-hapten. Frequently, 
more than 99% of early IgM responses were suppressed (8–13). 
IgG suppresses also primary IgG responses (14–16) and, when 
administered immediately prior to a secondary immunization, 
induction of a secondary antibody response (11). Whether IgG 
can suppress priming for a memory antibody response against 
SRBC is less clear. Some studies demonstrate that IgG-mediated 
suppression of priming does occur, although it is usually less 
efficient than suppression of a primary response (10, 14, 17, 18), 
while others find no suppression (19). IgG does not prevent prim-
ing of T helper cells (10, 15, 16).
The mechanism underlying IgG-mediated suppression has 
been intensely investigated over the years. Remarkably, no 
knockout mouse strain has been found in which suppression 
does not work. It operates well in mice lacking the activating 
Fc gamma receptors FcγRI, FcγRIII, and FcγRIV (FcRγ KO), 
the inhibitory FcγRIIB (FcγRIIB KO), the neonatal Fc receptor 
(FcRn) (β2-microglobulin KO) (10, 11, 20, 21), as well as com-
plement factor C1q (C1q KO), complement factor C3 (C3 KO), 
or complement receptors 1 and 2 (CR1/2 KO) (21). Moreover, 
a monoclonal IgG1 antibody, which is unable to activate 
complement, suppresses to the same degree as a complement-
activating IgG1 antibody (22). Therefore, it seems unlikely that 
IgG-mediated suppression is caused by complement-mediated 
lysis of SRBC. Because suppression is normal in FcγRIIB KO 
mice, it is also unlikely that IgG suppresses through central 
B-cell inhibition, where co-crosslinking of the negatively 
regulating immunoreceptor tyrosine-based inhibitory motif-
containing FcγRIIB and the B  cell receptor (BCR) induces 
inhibition of B cell signaling (23). Other mechanisms that could 
explain IgG-mediated suppression are that IgG increases clear-
ance, without involving complement or Fc-receptors, or that IgG 
masks epitopes on the antigen, and prevents B cells from binding 
and becoming activated. Clearance and epitope masking are 
not mutually exclusive, and mathematical modeling has sug-
gested that both are operative and can act synergistically (24). 
Passive administration of IgM of different affinities interferes 
with the development of germinal centers (GCs) and antibody 
production (25), but whether IgG regulates GC B cells has to our 
knowledge not been reported previously.
Here, the contribution of clearance and epitope masking has 
been studied in  vivo using passively administered polyclonal 
SRBC- or 4-hydroxy-3-nitrophenyl acetyl (NP)-specific IgG 
antibodies as suppressors. The data strongly suggest that epitope 
masking plays a major role for suppression of IgG responses 
because only responses against the epitopes recognized by IgG 
were suppressed. No correlation was observed between IgG-
mediated reduction of antigen in the spleen and suppression of 
the antibody response. In addition, we demonstrate for the first 
time that IgG suppresses the development of specific extrafol-
licular antibody-secreting cells, GC B cells as well as long-lived 
plasma cells. Finally, when primary antibody responses were 
suppressed to a very high degree (>96%), induction of immuno-
logical memory was suppressed to the same extent.
MaTerials anD MeThODs
Mice
C57BL/6JBomTac mice (C57BL/6) were from Taconic 
Bioscience, Inc. (Hudson, NY, USA) and BALB/c mice from 
Bommice (Ry, Denmark). Fc receptor gamma chain (FcRγ) 
KO founders were a gift from Ravetch et  al. (26) and were 
backcrossed to BALB/c for 10 generations. FcRγ KO mice 
lack the common FcRγ-chain and thereby all activating FcγRs 
associated with this chain (FcγRI, FcγRIII, and FcγRIV). Mice 
were age and sex matched within each experiment and were 
bred and maintained in the animal facilities of the National 
Veterinary Institute (Uppsala, Sweden). This study was carried 
out in accordance with the recommendations of the Uppsala 
Animal Research Ethics Committee and the protocol was 
approved by this committee.
antibodies and antigens Used for 
immunizations
Polyclonal IgGa anti-SRBC and polyclonal IgGa anti-NP were 
prepared from hyperimmune BALB/c serum and polyclonal IgGb 
anti-SRBC from hyperimmune C57BL/6 serum. IgG was purified 
by affinity chromatography over a Protein-A Sepharose column 
(Amersham Pharmacia Biotech, Uppsala, Sweden) (27), dialyzed 
against PBS, sterile filtered and stored at −20°C until use. IgGa 
anti-NP was biotinylated using 0.18 mg EZ-Link Sulfo-NHS-LC-
LC-Biotin (sulfosuccinimidyl-6-[biotinamido]-6-hexanamido 
hexaonate) (Thermo Scientific, Waltham, MA, USA) per 2  mg 
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IgG according to manufacturer’s recommendations. The reaction 
was performed at room temperature for 30 min and free biotin 
was removed by dialysis against PBS. IgGa anti-NP-biotin was 
sterile filtered and stored at 4°C until use. SRBC were acquired 
from Håtunalab AB (Håtunaholm, Sweden) and stored in sterile 
Alsever’s solution at 4°C. SRBC were washed three times in PBS 
before use. 4-hydroxy-3-nitrophenylacetic-e-aminocaproyl-OSu 
(NP-ε-Aminocaproyl-OSu) (Biosearch Technologies, Petaluma, 
CA, USA) was conjugated to SRBC as described before (16). 
Briefly, NP-ε-Aminocaproyl-OSu was dissolved in dimethyl-
formamide at a concentration of 7.5  mg/ml. Dissolved NP-ε-
Aminocaproyl-OSu were then added to 5% SRBC suspensions 
in conjugation buffer (0.1  M NaHCO3 with 0.15  M NaCl, pH 
8.5) to a final concentration of 250 μg/ml (in Figure  3, a final 
concentration of 1 mg/ml NP-ε-Aminocaproyl-OSu was used in 
order to achieve higher coupling ratio and facilitate visualization 
in sections) and incubated for 1  h at room temperature. After 
the conjugation reaction, cells were washed three times in PBS 
before use.
immunization and Blood sampling
All mice were immunized with SRBC or NP-SRBC in one of 
their lateral tail veins in 200 μl PBS. Antigen-specific IgG was 
always administered in 200 μl PBS 30  min prior to antigen, 
also via the lateral tail veins. Controls received antigen alone 
or antigen-specific IgG alone. Secondary immunizations were 
done with SRBC alone. Further details of doses are given in 
the figure legends. The “default” doses were 30–50  μg IgG 
and 5  ×  107 (NP-)SRBC, both of which are known cause 
90–99% suppression of antibody responses to this amount 
of erythrocytes. In studies of NP-specific antibody-secreting 
cells (Figure 3), the higher dose 5 × 108 NP-SRBC had to be 
used to induce detectable numbers of NP-specific cells and 
the dose of IgG was correspondingly increased to 100  μg. 
In  immunological memory experiments, the lower prim-
ing dose 5  ×  106 SRBC together with 10  μg IgG was used 
(Figure  5A) in addition to the default doses (Figure  5B) to 
test whether the strength of priming affected whether IgG 
was able to suppress memory induction or not. Blood was 
collected from the ventral tail artery.
enzyme-linked immunospot (elisPOT)
Enzyme-linked immunospot assay was used for measuring 
SRBC-specific IgG-secreting cells (28). Briefly, 96-well plates 
(Costar 96-well enzyme immunoassay/RIA; Sigma-Aldrich, St. 
Louis, MO, USA) were coated with 0.25% SRBC. Spleen cells 
were diluted in cell culture medium (DMEM with 0.5% FCS), 
100 μl was added to each well, and the plates were incubated 
at 37°C for 2.5  h. SRBC-specific antibodies produced by the 
single cells were detected after addition of goat anti-mouse IgG-
alkaline phosphatase (Jackson ImmunoResearch Laboratories, 
Inc., West Baltimore Pike, Media, PA, USA) for 3  h at room 
temperature, followed by addition of the precipitating substrate 
5-bromo-4-chloro-3-indolyl phosphate (Sigma-Aldrich) for 
30  min at room temperature. The plates were washed three 
times in PBS and samples were counted blindly under a 
stereomicroscope.
enzyme-linked immunosorbent 
assay (elisa)
Also NP- and SRBC-specific antibodies in sera were measured 
by ELISA (16). Briefly, 96-well plates (Costar 96-well enzyme 
immunoassay/RIA; Sigma-Aldrich) were coated with either 
100 μl 0.25% SRBC or 100 μl NP20-BSA (Biosearch Technologies) 
(50 μg/ml) in PBS with 0.05% NaN3. The plates were then blocked 
with 5% dry milk at 4°C overnight. After washing three times 
with PBS, serum samples were serially diluted, added to the plates, 
and incubated overnight at 4°C. When measuring secondary IgG 
responses, starting serum dilution for titer determination was 1:5. 
Cutoff for titers was set as mean OD405nm + 2× SD for a group of 
eight individual sera from naive BALB/c mice diluted 1:5 (29). 
When measuring the IgG response, depending on the allotype of 
injected antibodies, either biotinylated anti-IgG1b (clone B68-2) 
and anti-IgG2ab (clone 5.7) or biotinylated anti-IgG1a (clone 10.9) 
and anti-IgG2aa (clone 8.3) (all from BD Pharmingen, San Jose, 
CA, USA) were mixed 1:1, added to each well, and incubated 
overnight at 4°C. After washing, alkaline phosphatase-conjugated 
streptavidin (BD Pharmingen, San Jose, CA, USA) was added 
and incubated for 3 h at room temperature. After washing, plates 
were developed using the substrate (p-nitrophenylphosphate; 
Sigma-Aldrich). Absorbance at 405 nm was measured and data 
analyzed using SoftMax software (Molecular Devices, Sunnyvale, 
CA, USA).
Flow cytometry
Spleen cells were prepared as described before (30) and re-sus-
pended in FACS buffer (PBS with 2% fetal bovine serum). Samples 
were treated with Fc block (anti-CD16/32; BD Biosciences, 
San Jose, CA, USA) for 10 min on ice, then stained with anti-
B220-Alexa700 (clone RA3-6B2), anti-GL7-BV421 (clone GL7), 
anti-CD95-PEcy7 (clone Jo2), anti-λ1-biotin (clone R11-153) (all 
from BD Biosciences) at 4°C for 30 min. After washing twice in 
FACS buffer, samples were stained with streptavidin-FITC and 
NP-PE at 4°C for 30 min and re-suspended in 300 μl FACS buffer 
after washing in FACS buffer. For each sample, 2–3 million events 
were acquired on a LSR Fortessa cytometer (BD Biosciences) at 
the BioVis platform, SciLifeLab, Uppsala, Sweden. Data were ana-
lyzed with FlowJo software (Tree Star Inc., Ashland, OR, USA).
confocal laser scanning Microscopy
Spleens were harvested, embedded in optimal cutting tempera-
ture embedding compound (VWR international, Radnor, PA, 
USA), flash-frozen in liquid nitrogen, and stored at −80°C. Eight-
micrometer sections were cut using Thermo Scientific CryoStar 
NX70 Cryostat (Thermo Scientific, Waltham, MA, USA), 
thaw-mounted on frost plus microscope slides (Menzel-Gläser, 
Braunschweig, Germany), air-dried and stored at −80°C until 
use. Prior to staining, slides were fixed in 4% paraformaldehyde 
(Merck, Darmstadt, Germany) in PBS (pH 7.8) for 15 min or in 
50% acetone for 30 s followed by 100% acetone (Sigma-Aldrich) 
for 5 min. Slides were then rehydrated in PBS and blocked with 
5% horse serum (Sigma-Aldrich) in PBS for 30 min. Slides were 
stained with primary antibodies for 1 h. After washing twice in 
PBS, fluorochrome-conjugated streptavidin was added and the 
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slides were incubated for 1 h and washed twice in PBS prior to 
mounting with Fluoromount G (Southern Biotech, Birmingham, 
AL, USA). For detection of NP-specific B  cells, slides were 
stained with anti-IgD-Alexa 488 (clone 11-26C.2a, BioLegend, 
San Diego, CA, USA) and NP-PE (Biosearch Technologies). 
Localization of SRBC to splenic marginal zones (MZs) were 
investigated using anti-B220-Pacific blue (clone RA3-6B2, BD 
Biosciences), anti-CD169 (MOMA)-FITC (clone MOMA-1, 
AbD Serotec, Raleigh, NC, USA), and NP-SRBC detection by 
an in-house produced polyclonal IgG anti-NP-biotin followed 
by streptavidin-PE (eBioscience, San Diego, CA, USA). Images 
of immunofluorescence were acquired blindly and randomized 
with a LSM 700 confocal microscope (Carl Zeiss, Thornwood, 
NY, USA) using Zen 2009 software (Carl Zeiss). Tile-scan 
images of whole spleen sections were acquired using Zen 2009 
software. Images were analyzed blindly with ImageJ software 
(NIH, Bethesda, MD, USA).
statistical analysis
Statistical differences between groups were determined by the 
two-tailed Student’s t-test. Statistical significance levels were set 
as: ns, p > 0.05; *p < 0.05; **p < 0.01; ***p < 0.001.
resUlTs
igg-Mediated Decrease of the amount of 
srBc in the spleen is Dependent on 
activating Fcγrs and Does not correlate 
with suppression
Specific IgG administered together with SRBC reduces the locali-
zation of SRBC in the MZ of the spleen and increases clearance 
of SRBC from the blood (16). However, after 10 min, the levels of 
SRBC in the circulation were undetectable, regardless of whether 
IgG had been co-administered or not (16). The correlation 
between suppression and antigen localization was not directly 
assessed nor was the importance of FcγRs studied. To investigate 
this, BALB/c and FcRγ KO mice were immunized with IgG anti-
SRBC +  5 ×  107 NP-SRBC, 5 ×  107 NP-SRBC alone, or with 
1 ×  107 NP-SRBC alone. Spleens were harvested after 10  min 
and the amount of extracellular NP-SRBC was determined by 
confocal laser scanning microscopy (Figures 1A–R; enhanced 
images are shown in Figure S1 in Supplementary Material). 
In parallel, the serum IgG anti-SRBC response was followed 
in groups of mice immunized at the same time (Figure  1S). 
Because the passively administered IgG was obtained from mice 
with a different IgG allotype than the recipient mice, the actively 
produced endogenous IgG antibodies could be distinguished 
by an allotype-specific ELISA (21). Administration of IgG 
significantly reduced the amount of SRBC in the MZ of wild-
type BALB/c mice (Figures 1B,F vs. Figures 1A,E; Figure 1Q) 
as well as in the entire spleen section (Figure  1R; Figure S2 
in Supplementary Material). BALB/c mice immunized with 
1 ×  107 NP-SRBC alone, or with the fivefold higher amount 
of NP-SRBC together with IgG anti-SRBC, had comparable 
amounts of NP-SRBC in their spleens (Figures 1C,G,R). In spite 
of this, mice immunized with 1 × 107 NP-SRBC alone mounted a 
potent antibody response while mice immunized with IgG anti-
SRBC + 5 × 107 NP-SRBC had a suppressed antibody response 
(Figure 1S). Some spleens were also analyzed for NP-SRBC after 
1 h and 24 h, but, as expected, very little or no antigen could be 
detected at these time points [Ref. (31) and data not shown]. 
In FcRγ KO mice, IgG was unable reduce the amount of SRBC in 
the MZ (Figures 1J,N,Q) and in the entire spleen (Figure 1R). 
In spite of the similar amounts of SRBC in the spleens, the 
antibody response was suppressed in the IgG group (Figure 1S).
In summary, in BALB/c mice, equal (low) levels of antigen in 
the spleen can result in high (1 × 107 NP-SRBC-group) or sup-
pressed (IgG + 5 × 107 NP-SRBC-group) antibody responses. In 
FcγR KO mice, equal (high) levels of antigen can result in high 
(5 × 107 NP-SRBC) or suppressed (IgG + 5 × 107 NP-SRBC-group) 
antibody responses. This lack of correlation between suppression 
and the amount of NP-SRBC detected in the spleen is hard to 
reconcile with clearance of antigen as the major explanation for 
IgG-mediated suppression. Moreover, the observations confirm 
that administration of SRBC-specific IgG reduces the amount 
of antigen localized in the spleen (16) and demonstrate that the 
reduction is dependent on activating FcγRs while the suppression 
of antibody responses is not.
epitope-specific suppression of igg 
responses
Next, we sought to determine whether IgG only suppresses 
responses against the epitopes to which it binds (epitope-specific 
suppression) or whether it, in addition, suppresses responses 
against other epitopes on the same antigen (non-epitope specific 
suppression). To this end, C57BL/6 mice were immunized with 
NP-SRBC alone or together with either IgG anti-NP or IgG 
anti-SRBC. The mice were bled every 2 weeks and their antibody 
responses against NP and SRBC were analyzed. IgG anti-NP 
suppressed the NP- but not the SRBC-specific IgG-responses 
(Figures 2A,B) while IgG anti-SRBC suppressed the SRBC- but 
not the NP-specific IgG response (Figures 2C,D). These observa-
tions were highly reproducible (4/4 experiments with IgG anti-
NP and 2/2 with IgG anti-SRBC) and demonstrate that IgG is able 
to suppress IgG responses in an epitope-specific way.
igg suppresses nP-specific extrafollicular 
antibody-secreting cells and nP-specific 
gc B cells
In previous studies, the ability of IgG to suppress the overall 
serum antibody levels or splenic antibody-secreting cells was 
analyzed. Here, we investigated which B cell subpopulations were 
suppressed by IgG, using a system in which the BCRs of the 
antigen-specific B cells could be stained directly. The antibody 
response against NP in C57BL/6 mice is genetically restricted, 
mainly comprising λ1 light chains and the V186.2 segment of 
the VHJ558 gene family (32). Therefore, staining for λ1 and NP 
can be used to identify NP-specific B cells. C57BL/6 mice were 
immunized with NP-SRBC ± IgG anti-NP and negative controls 
with unconjugated SRBC or left unimmunized. Six days later, 
spleens were analyzed for NP-binding cells with flow cytometry 
and confocal microscopy (Figure 3). In mice immunized with 
FigUre 1 | continued
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FigUre 2 | epitope-specific suppression of igg responses. C57BL/6 
mice were immunized with 5 × 107 NP-sheep red blood cells (SRBC) ± 30 μg 
IgGa anti-NP or (a,B) with 5 × 107 NP-SRBC ± 30 μg IgGa anti-SRBC (c,D). 
IgG was also administered alone as negative control. Serum samples were 
diluted 1:125 and analyzed in enzyme-linked immunosorbent assay. 
Representative of four (a,B) or two (c,D) experiments; n = 5 mice/group 
(except for IgG alone where n = 2 mice/group). Statistical comparisons were 
done between solid circles vs. open circles in (a,B) and between solid circles 
vs. open squares in (c,D). ns, p > 0.05; *p < 0.05; **p < 0.01; ***p < 0.001.
FigUre 1 | continued 
igg-mediated decrease of the amount of sheep red blood cell (srBc) in the spleen is dependent on activating Fcγrs and does not correlate with 
suppression. BALB/c and FcRγ KO mice were immunized with 5 × 107 NP-SRBC ± 50 μg IgGb anti-SRBC or 1 × 107 NP-SRBC. Naive mice and mice-receiving 
IgGb anti-SRBC alone were used as negative controls. Spleens were harvested 10 min after administration of NP-SRBC and processed for analysis by confocal 
laser scanning microscopy (n = 5/group). (a–P) Visualization of NP-SRBC localization in spleen sections: B220+ B cells (blue), MOMA+ metallophilic macrophages 
(green), and NP-SRBC (red). Imaging of samples was performed blindly. (Q) Quantification of the number of NP-SRBC per marginal zone. Ten to fifteen randomly 
selected follicles per spleen per mouse were imaged at 20× magnification. (r) Quantification of the number of NP-SRBC per millimeter square in whole spleen 
sections. Tile scans of one whole spleen section per mouse were imaged at 10× magnification. (s) The IgG anti-SRBC response was followed in parallel in mice 
from each group for 7–35 days after immunization (n = 5/group, n = 3 for negative controls). Sera diluted 1:125 were screened for IgGa anti-SRBC in enzyme-linked 
immunosorbent assay. p-Values for comparisons of mice immunized with IgG anti-SRBC and NP-SRBC vs 5 × 107 NP-SRBC alone are given without parentheses. 
Comparisons of mice immunized with IgG anti-SRBC and 5 × 107 NP-SRBC vs 1 × 107 NP-SRBC alone are given within parentheses. Data are representative of 
two (S: BALB/c), one (S: FcRγ KO), or at least three experiments (a–r). ns, p > 0.05; *p < 0.05; **p < 0.01; ***p < 0.001.
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NP-SRBC alone, a small population of λ1+NP+B220+ cells 
were identified both among the GL7high CD95high GC B  cells 
(Figure  3B bottom right panel; Figure  3C) and among the 
GL7lowCD95low non-GC B  cells (Figure  3B bottom left panel; 
Figure  3C). The NP-specific cells (GC B  cells and non-GC 
B  cells together) constituted approximately 0.05% of the total 
B220+ population and ~1/5 were GC B cells and ~4/5 non-GC 
B  cells (Figure  3C). Administration of IgG anti-NP together 
with NP-SRBC abolished the induction of NP-specific GC and 
non-GC B cells (Figures 3A,C). In fact, the levels in these mice 
were equally low as in mice immunized with unconjugated SRBC 
or left untreated (Figure 3C).
The other half of the spleens were analyzed in confocal 
microscopy (Figures  3D–I). NP-binding cells were readily 
detected in extrafollicular foci in mice immunized with NP-SRBC 
(Figure 3E) while very few NP-binding cells were detected in 
mice immunized with IgG anti-NP +  NP-SRBC (Figure  3D) 
and in the negative controls (Figures 3F,G). Although it cannot 
be excluded that some of the NP-binding cells in extrafollicular 
foci had exited GCs, the majority are presumably true extrafol-
licular cells owing to the early time point at which they were 
analyzed. Importantly, all NP-specific cells outside the follicles, 
regardless of their origin, are absent in mice immunized with IgG 
anti-NP + NP-SRBC. NP-specific cells could also be detected in 
some GCs (Figure  3H). GC B  cells stained less brightly than 
the extrafollicular NP-specific cells possibly due to a wider 
span in affinity (33) and lower Ig expression. To confirm that 
the unstained areas close to the IgD+ areas are indeed GCs, co-
staining with PNA was performed (Figure S3 in Supplementary 
Material). In summary, IgG anti-NP can suppress the generation 
of both extrafollicular NP-specific antibody-secreting cells and 
NP-specific GC B cells.
igg suppresses the generation of  
long-lived Plasma cells
To determine whether IgG suppressed the development of 
long-lived plasma cells, mice were immunized with SRBC ± IgG 
anti-SRBC and the number of SRBC-specific IgG-secreting cells 
in the spleen and bone marrow was analyzed 5–70  days after 
immunization (Figure  4). Cells secreting IgG anti-SRBC were 
detected in both organs at all times, but were severely suppressed 
in the groups receiving IgG together with SRBC. As expected, 
the number of antibody-producing cells in the spleen was highest 
early after immunization and then decreased, while the cell num-
ber in the bone marrow increased during the entire time period. 
Thus, administration of IgG anti-SRBC efficiently suppressed the 
specific IgG-secreting cells at all times, both in spleen and bone 
marrow.
igg suppresses induction of 
immunological Memory
To test the ability of IgG to regulate memory induction, BALB/c 
mice were immunized in two regimes: 5 × 107 SRBC ± 50 μg 
IgG anti-SRBC or 5 × 106 SRBC ± 10 μg IgG anti-SRBC. The 
IgG anti-SRBC responses were followed during 63  days after 
priming, confirming efficient suppression (Figures  5A,B). 
And, 70  days after priming, all mice were boosted with a 
suboptimal number of SRBC and, in addition, a group of naive 
mice received the same “booster” dose. Because of the great 
differences in antibody levels between the groups, we analyzed 
the antibody responses as endpoint titers, starting at a serum 
dilution of 1:5. In mice that had been primed with SRBC alone 
FigUre 3 | continued
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and boosted, a very high  secondary antibody response was 
observed (Figures  5A,B). In  mice primed with IgG +  SRBC 
and boosted, secondary responses were low (Figures  5A,B). 
A minute priming effect was, however, visible also in the IgG 
groups, evidenced by the fact that their antibody titers were 
higher than those in naive and “boosted” mice (Figures 5A,B). 
Naive mice, primed on day 70 with the suboptimal dose 5 × 105 
SRBC, produce low titers of IgG antibodies [mean titers: 30 
(Figure 5A) and 1,100 (Figure 5B)], which are barely visible in 
the figures. The relative suppression of primary responses and 
induction of memory appeared to be equal. In the low dose 
experiment, IgG suppressed 96% of the IgG-response on day 
21 and 99% on day 91 (21  days after boost) (Figure  5A). In 
the high dose experiment, suppression was 97% both 21  days 
after priming and 21 days after boost (Figure 5B). Thus, when 
IgG-mediated suppression of primary antibody responses is very 
efficient, priming for secondary antibody responses seems to 
follow along the same lines.
DiscUssiOn
Generation of an adaptive antibody response is a complicated 
process, and one purpose of the present investigation was to 
define in detail which parameters along this line that can be 
suppressed by IgG. After the initial interaction between antigen, 
B cells, and cognate T cells, the specific B cells can differentiate 
into extrafollicular short-lived IgM- or IgG-secreting cells, or 
GC-independent memory B  cells. Other B  cells enter the GC 
pathway, go through hypermutation followed by selection for 
high affinity and class switch recombination becoming either 
GC-dependent memory B  cells or long-lived plasma cells 
[reviewed in Ref. (34–36)]. Differentiation between IgG-mediated 
suppression of extrafollicular B  cells, non-GC B  cells, and GC 
B  cells in the spleen is not possible by just looking at serum 
antibodies or direct plaque-forming cell assay. In order to detect 
single antigen-specific B cells in vivo, usually Ig-transgenic mice 
immunized with antigen in adjuvants are used. Here, we managed 
FigUre 3 | igg suppresses nP-specific extrafollicular antibody secreting cells and nP-specific germinal centers (gcs) B cells. C57BL/6 mice were 
immunized with 5 × 108 NP-sheep red blood cell (SRBC) ± 100 μg polyclonal IgGa anti-NP, 5 × 108 unconjugated SRBC, or left untreated. After 6 days, spleens 
were harvested and half of the spleen samples were analyzed with flow cytometry (a–c) and the other half with confocal microscopy (D–i). (a,B) Gating strategy for 
GC and non-GC NP+λ1+ cells. (c) Frequency of GC and non-GC NP+λ1+ cells among total B220+ cells. (D–g) Representative tile scan sections, stained for IgD+ 
(blue), and NP+ (red) cells. (h) Enlarged image from (e) (square with dashed lines). (i) Quantification of fluorescence intensity per square micrometer. One 
representative tile scan image was taken from each mouse and the intensity of red fluorescence (NP+) from each image was summed and then divided by the size of 
the image. Representative of three independent experiments with 2–4 mice/group. ns, p > 0.05; *p < 0.05; **p < 0.01; ***p < 0.001.
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to set up a system in which i.v. immunization of C57BL/6 mice 
with 5 ×  108 NP-SRBC in PBS resulted in NP-specific B  cell 
populations, which were detectable through staining of specific 
BCR with NP-PE. Administration of IgG anti-NP completely 
prevented development of NP-specific extrafollicular B  cells, 
non-GC B cells, and GC B cells (Figure 3). IgG anti-SRBC also 
suppressed the development of long-lived plasma cells in bone 
marrow obtained up to 70 days after immunization (Figure 4).
An important function of the adaptive immune system is the 
generation of long-lived memory B cells. Whether IgG, acting to 
suppress a primary response, also inhibits priming for immuno-
logical memory has not been unequivocally determined (10, 14, 
17–19). By using an ELISA that discriminates between passively 
administered and actively produced, endogenous IgG, and by 
measuring the IgG levels in the serum as endpoint titers, we could 
directly compare the relative suppression of primary and second-
ary IgG responses. The data show that when primary responses 
were suppressed by 96% or more, secondary responses were 
also suppressed by 96% or more. Thus, the relative suppression 
of a primary IgG response and priming for a secondary IgG 
response is very similar (Figure  5). This is in accordance with 
current knowledge about the development of memory B  cells, 
most of which are generated during the first weeks of an immu-
nization (36). Therefore, it would be expected that lack of B cell 
stimulation, owing to IgG-mediated inhibition of the interaction 
between antigen and B cells, during this time, would result in lack 
of memory B cells. When the primary B cell response is only par-
tially suppressed, a partial suppression of priming would be the 
logical result, and this may explain why priming has sometimes 
been found to be only moderately suppressed. The observation is 
also consistent with the successful RhD prophylaxis in humans 
in which administration of IgG anti-RhD to women at the first 
pregnancy with a RhD-positive baby protects against immuniza-
tion during the next pregnancy (6, 7).
To further elucidate the mechanism underlying IgG-mediated 
suppression, we focused on differentiating between the two 
hypotheses that are currently mainly discussed, antigen clearance 
and epitope masking. Provided FcγRs were expressed in the mice, 
FigUre 5 | igg suppresses the induction of immunological memory. BALB/c mice were immunized with 5 × 106 sheep red blood cell (SRBC) ± 10 μg IgGb 
anti-SRBC+ or (a) or 5 × 107 SRBC ± 50 μg IgGb anti-SRBC (B). And, 70 days after priming, all mice were boosted with 5 × 105 sheep red blood cells (SRBCs). An 
additional, unprimed, group also received 5 × 105 SRBC at this time point (filled triangles). Serum IgGa anti-SRBC titers were assayed in enzyme-linked 
immunosorbent assay. p-Values for comparisons between mice primed with IgG anti-SRBC and 5 × 107 SRBC vs. 5 × 107 SRBC alone are given without 
parentheses. Comparisons between mice primed with IgG anti-SRBC and SRBC and boosted with 5 × 105 SRBC vs. naive mice “boosted” with 5 × 105 SRBC 
alone are given within parentheses. Data are representative of at least three experiments per antigen dose (n = 5–8/group). ns, p > 0.05; **p < 0.01; ***p < 0.001.
FigUre 4 | igg suppresses the generation of long-lived plasma cells. 
BALB/c mice were immunized with 5 × 107 sheep red blood cell 
(SRBC) ± 30 μg IgGb anti-SRBC. Spleens and bone marrow were harvested 
and SRBC-specific antibody-secreting cells were measured with ELISPOT. 
Comparisons between filled and open triangles are given without 
parentheses and comparisons between filled and open squares are given 
within parentheses. ns, p > 0.05; *p < 0.05; **p < 0.01; ***p < 0.001.
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IgG was able to increase clearance, but no correlation between 
the antibody response and the amount of NP-SRBC found in the 
spleens was observed (Figure  1). These findings are consistent 
with previous observations. IgG administered several days after 
SRBC causes suppression (11, 12, 37–40) in spite of the fact that 
SRBC is cleared from the circulation of mice within 10 min of 
immunization (16). In a model using as antigen transgenic mouse 
erythrocytes (HOD-RBC), which express hen egg lysozyme in 
tandem sequence with T cell determinants of ovalbumin (OVA) 
and the complete human Duffyb transmembrane protein (41), 
a panel of monoclonal IgG antibodies were tested for ability 
to suppress the OVA-specific antibody response. Three of the 
antibodies induced clearance while three did not, but all six were 
efficient suppressors (42). In addition, monoclonal anti-RhD 
administered together with RhD+ erythrocytes to RhD− subjects 
induced rapid clearance of erythrocytes but failed to suppress the 
antibody response (43, 44).
Direct evidence for a role of epitope masking in IgG-mediated 
suppression is difficult to obtain, and this hypothesis will prob-
ably remain a “diagnosis by exclusion.” Epitope masking by IgM 
antibodies was, however, suggested to play an important role in 
selection of B cells in germinal centers (25), and to be the most 
important explanation for poor secondary antibody responses to 
the stem of the influenza surface hemagglutinin during vaccina-
tions (45). The highly reproducible epitope specificity of suppres-
sion of the IgG responses shown in Figure 2 lends strong support 
for the epitope masking hypothesis. This finding may be the clos-
est to a direct proof for the epitope masking hypothesis, which is 
possible to obtain. Importantly, epitope specificity of suppression 
has been reported previously (12, 46). However, also non-epitope 
specific suppression has been observed, mainly in systems 
studying IgM-producing single B  cells during the first week of 
immunization (4, 9, 10, 13, 16, 22, 42). Because non-epitope 
specificity has been interpreted as evidence for Fc-dependence 
of suppression and, therefore, to argue against the epitope 
masking mechanism, this is an important issue. The existence 
of non-epitope specific suppression needs to be accommodated 
with the increasing support for Fc-independence of suppression 
obtained from studies of FcγR- and complement-deficient mice 
(10, 11, 20–22) and the observations that F(ab′)2 fragments can 
suppress (10, 20, 47, 48). We have suggested (10, 49), and still 
believe, that the best explanation for the apparent paradox of lack 
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